<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">91362</article-id><article-id pub-id-type="doi">10.7554/eLife.91362</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>High-content microscopy reveals a morphological signature of bortezomib resistance</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-328964"><name><surname>Kelley</surname><given-names>Megan E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0251-5054</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-328965"><name><surname>Berman</surname><given-names>Adi Y</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-328966"><name><surname>Stirling</surname><given-names>David R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6802-4103</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-176742"><name><surname>Cimini</surname><given-names>Beth A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9640-9318</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-328967"><name><surname>Han</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77115"><name><surname>Singh</surname><given-names>Shantanu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3150-3025</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-76519"><name><surname>Carpenter</surname><given-names>Anne E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1555-8261</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-274995"><name><surname>Kapoor</surname><given-names>Tarun M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-328968"><name><surname>Way</surname><given-names>Gregory P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0503-9348</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Laboratory of Chemistry and Cell Biology</institution>, <institution>Rockefeller University</institution>, <addr-line><named-content content-type="city">New York City</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Imaging Platform</institution>, <institution>Broad Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Biomedical Informatics</institution>, <institution>University of Colorado Anschutz Medical Campus</institution>, <addr-line><named-content content-type="city">Aurora</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-156274"><name><surname>Liu</surname><given-names>Caigang</given-names></name><role>Reviewing editor</role><aff><institution>Shengjing Hospital of China Medical University</institution>, <country>China</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>anne@broadinstitute.org</email> (AC);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>kapoor@rockefeller.edu</email> (TK);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>Gregory.way@cuanschutz.edu</email> (GW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>09</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e91362</elocation-id><history><date date-type="received"><day>27</day><month>07</month><year>2023</year></date><date date-type="accepted"><day>13</day><month>09</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Kelley et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Kelley et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-91362-v1.pdf"/><abstract><p>Drug resistance is a challenge in anticancer therapy. In many cases, cancers can be resistant to the drug prior to exposure, i.e., possess intrinsic drug resistance. However, we lack target-independent methods to anticipate resistance in cancer cell lines or characterize intrinsic drug resistance without a priori knowledge of its cause. We hypothesized that cell morphology could provide an unbiased readout of drug resistance. To test this hypothesis, we used HCT116 cells, a mismatch repair-deficient cancer cell line, to isolate clones that were resistant or sensitive to bortezomib, a well-characterized proteasome inhibitor and anticancer drug to which many cancer cells possess intrinsic resistance. We then expanded these clones and measured high-dimensional single-cell morphology profiles using Cell Painting, a high-content microscopy assay. Our imaging- and computation-based profiling pipeline identified morphological features that differed between resistant and sensitive cells. We used these features to generate a morphological signature of bortezomib resistance. We then employed this morphological signature to analyze a set of HCT116 clones (five resistant and five sensitive) that had not been included in the signature training dataset, and correctly predicted sensitivity to bortezomib in seven cases, in the absence of drug treatment. This signature predicted bortezomib resistance better than resistance to other drugs targeting the ubiquitin-proteasome system. Our results establish a proof-of-concept framework for the unbiased analysis of drug resistance using high-content microscopy of cancer cells, in the absence of drug treatment.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Starr Cancer Consortium</institution></institution-wrap></funding-source><award-id>112-0039</award-id><principal-award-recipient><name><surname>Carpenter</surname><given-names>Anne E</given-names></name><name><surname>Kapoor</surname><given-names>Tarun M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35 GM122547</award-id><principal-award-recipient><name><surname>Carpenter</surname><given-names>Anne E</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35 GM130234</award-id><principal-award-recipient><name><surname>Kapoor</surname><given-names>Tarun M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 GM066699</award-id><principal-award-recipient><name><surname>Kelley</surname><given-names>Megan E</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 GM115327</award-id><principal-award-recipient><name><surname>Berman</surname><given-names>Adi Y</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>NSF GRFP 2019272977</award-id><principal-award-recipient><name><surname>Berman</surname><given-names>Adi Y</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated during this study are provided in the dataset cpg0028-kelley-resistance, available in the Cell Painting Gallery on the Registry of Open Data on AWS (https://registry.opendata.aws/cellpainting-gallery/). Processed data, source data files, and code to reproduce this analysis are available at https://github.com/broadinstitute/profiling-resistance-mechanisms (Way et al., 2023).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kelley ME</collab><collab>Berman AY</collab><collab>Stirling DR</collab><collab>Cimini BA</collab><collab>Han Y</collab><collab>Singh S</collab><collab>Carpenter AE</collab><collab>Kapoor TM</collab><collab>Way GP</collab></person-group><year iso-8601-date="2023">2023</year><source>Cell Painting images to produce a high-content phenotypic signature of Bortezomib resistance</source><ext-link ext-link-type="uri" xlink:href="https://registry.opendata.aws/cellpainting-gallery/">https://registry.opendata.aws/cellpainting-gallery/</ext-link><comment>Registry of Open Data on AWS</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-91362-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>